Evidence supports an indirect relationship mediated by weight reduction, improved insulin sensitivity, and normalization of hormonal and inflammatory pathways
It offers brand-name GLP-1s, along with personalized guidance, check-ins, and side-effect support, which may include additional medication
It is an off-label practice to potentially reduce the monthly expenses of Ozempic and Wegovy, mitigate the severity of gastrointestinal side effects, and prevent weight regain in the maintenance phase
They help to reduce appetite, accelerate metabolism, and provide long-term medical weight loss benefits
Implications for Drug Testing These principles and factors are foundational in designing drug tests and interpreting their outcomes
Glucagon-like peptide 1 receptor agonists in end-staged kidney disease and kidney transplantation: A narrative review